Finance

Lists
Why is CPHI up 6,98%?
Dive Deeper
CPHI:NYSEAMERICAN
China Pharma Holdings Inc
0,73 USD
+6,98%
(+0,048) 1D
0,71 USD
-2,46% (-0,018)
Pre-market
Closed: 15-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CPHI...
Open
0,72 USD
High
0,74 USD
Low
0,67 USD
Mkt. cap
31,37 млн
Avg. vol.
3,22 млн
Volume
4,36 миң
52-wk high
19,19 USD
52-wk low
0,38 USD
EPS
-0,43 USD
Beta
1,04
Shares outstanding
43,02 млн
No. of employees
215
Open
0,72 USD
High
0,74 USD
Low
0,67 USD
Mkt. cap
31,37 млн
Avg. vol.
3,22 млн
Volume
4,36 миң
52-wk high
19,19 USD
52-wk low
0,38 USD
EPS
-0,43 USD
Beta
1,04
Shares outstanding
43,02 млн
No. of employees
215
News stories
From web sources and news partners
About China Pharma Holdings Inc
CEO-
Employees215
Founded1993
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
756,22 миң
1,23 млн
983,54 миң
948,34 миң
Cost of goods sold
815,87 миң
1,08 млн
698,05 миң
864,77 миң
Cost of revenue
815,87 миң
1,08 млн
698,05 миң
864,77 миң
Research and development expenses
39,91 миң
189,59 миң
83,76 миң
19,14 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
502,87 миң
1,19 млн
1,32 млн
1,49 млн
Operating expense
568,08 миң
1,35 млн
1,40 млн
1,52 млн
Total operating expenses
1,38 млн
2,43 млн
2,10 млн
2,38 млн
Operating income
-627,73 миң
-1,20 млн
-1,12 млн
-1,43 млн
Other non operating income
-
-
-
-
EBT including unusual items
-651,48 миң
-1,22 млн
-1,14 млн
-1,46 млн
EBT excluding unusual items
-651,48 миң
-1,22 млн
-1,14 млн
-1,46 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-651,48 миң
-1,22 млн
-1,14 млн
-1,46 млн
Net profit margin
-86,15%
-99,68%
-116,23%
-153,76%
Earnings per share
-
-
-
-
Interest and investment income
294,00
213,00
147,00
81,00
Interest expense
-24,05 миң
-22,60 миң
-26,03 миң
-26,36 миң
Net interest expenses
-23,75 миң
-22,39 миң
-25,88 миң
-26,28 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-271,70 миң
-702,32 миң
-136,69 миң
-329,99 миң
Gain or loss from assets sale
-
-
1,45 миң
1,92 миң
AI content may include mistakes. Learn more
Google колдонмолору